Real-time enrollment status for this bladder cancer clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 4:55 PM UTC
| NCT Number | NCT06567743 |
| Recruiting Status | Recruiting |
| Condition | Bladder Cancer |
| Phase | PHASE2 |
| Target Enrollment | 325 participants |
| Active Locations | 65 sites in the US |
| Sponsor | CG Oncology, Inc. |
| Last Updated on CT.gov | April 8, 2026 (Apr 8, 2026) |
As of July 17, 2026: Clinical trial NCT06567743 is currently recruiting participants. This phase2 study for bladder cancer is actively seeking new participants at 65 locations across the United States. The study is sponsored by CG Oncology, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06567743 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 65 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06567743 was last updated Apr 8, 2026 (April 8, 2026). HelloStudys verifies this status automatically.